Twelve patients were initially diagnosed as anaplastic astrocytoma, IDH-wildtype, and reclassified as H3-wildtype and IDH-wildtype diffuse pediatric-type high-grade glioma according to the 2021 WHO classification of CNS tumors (Louis et al., 2016). The gene discussed is IDH1; the disease is central nervous system neoplasm.